While BLA is an established option in CD following failed trans-sphenoidal surgery,[23, 24] it has also been described with success for patients with CAH[26, 27] and ectopic ACTH production, where the site of overproduction is not detected.[11] The same was the experience in the present series. The gene discussed is POMC; the disease is congenital adrenal hyperplasia.